brentuximab vedotin,bortezomib,rovalpituzumab tesirine,brepocitinib,vedolizumab,daxdilimab
takeda,abbvie,amgen,pfizer,seagen
['rova,(-approval),(-microvascular)', ' vedo', ' aa ', 'brentuximab', 'daxdilimab', 'brepocitinib', 'lupus', 'borte', 'vedo']
 precision medecine in #lupus. great to see our work quoted at #eular2023 the pipeline of targeted treatments in #sle to get the full paper and learn more about these 92 drugs go to: 
MD, PhD | Professor of #Rheumatology | #Lupus #SLE | #Digitalhealth | President of @SLEuroSociety | @ERN_ReCONNET Disease Coordinator for Lupus & RP 🇪🇺